Annual SG&A
$34.71 M
+$2.85 M+8.94%
31 December 2023
Summary:
Century Therapeutics annual selling, general & administrative expenses is currently $34.71 million, with the most recent change of +$2.85 million (+8.94%) on 31 December 2023. During the last 3 years, it has risen by +$25.21 million (+265.52%). IPSC annual SG&A is now at all-time high.IPSC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$8.35 M
+$46.00 K+0.55%
30 September 2024
Summary:
Century Therapeutics quarterly selling, general & administrative expenses is currently $8.35 million, with the most recent change of +$46.00 thousand (+0.55%) on 30 September 2024. Over the past year, it has dropped by -$634.00 thousand (-7.06%). IPSC quarterly SG&A is now -7.06% below its all-time high of $8.99 million, reached on 30 September 2023.IPSC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.80 B
-$129.89 M-4.86%
30 September 2024
Summary:
Century Therapeutics TTM selling, general & administrative expenses is currently -$2.80 billion, with the most recent change of -$129.89 million (-4.86%) on 30 September 2024. Over the past year, it has dropped by -$2.84 billion (-8251.90%). IPSC TTM SG&A is now -858.09% below its all-time high of $34.71 million, reached on 31 December 2023.IPSC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.9% | -7.1% | -8251.9% |
| 3 y3 years | +265.5% | +33.0% | -10000.0% |
| 5 y5 years | - | - | - |
IPSC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +265.5% | -7.1% | +35.2% | -116.0% | at low |
| 5 y | 5 years | at high | +501.8% | -7.1% | +307.4% | -858.1% | at low |
| alltime | all time | at high | +501.8% | -7.1% | +307.4% | -858.1% | at low |
Century Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.35 M(+0.6%) | $33.99 M(-1.8%) |
| June 2024 | - | $8.31 M(-5.0%) | $34.62 M(+0.2%) |
| Mar 2024 | - | $8.74 M(+1.8%) | $34.55 M(-0.5%) |
| Dec 2023 | $34.71 M(+8.9%) | $8.59 M(-4.4%) | $34.71 M(+1.0%) |
| Sept 2023 | - | $8.99 M(+9.2%) | $34.36 M(+2.8%) |
| June 2023 | - | $8.23 M(-7.6%) | $33.44 M(-0.1%) |
| Mar 2023 | - | $8.90 M(+8.0%) | $33.46 M(+5.0%) |
| Dec 2022 | $31.86 M | $8.24 M(+2.2%) | $31.86 M(+6.9%) |
| Sept 2022 | - | $8.06 M(-2.3%) | $29.79 M(+6.4%) |
| June 2022 | - | $8.25 M(+13.1%) | $28.01 M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $7.30 M(+18.1%) | $23.84 M(+24.0%) |
| Dec 2021 | $19.23 M(+102.6%) | $6.18 M(-1.7%) | $19.23 M(+21.2%) |
| Sept 2021 | - | $6.28 M(+53.7%) | $15.87 M(+33.3%) |
| June 2021 | - | $4.09 M(+52.1%) | $11.91 M(+17.5%) |
| Mar 2021 | - | $2.69 M(-4.5%) | $10.13 M(+6.7%) |
| Dec 2020 | $9.49 M(+64.6%) | $2.82 M(+21.4%) | $9.49 M(+42.2%) |
| Sept 2020 | - | $2.32 M(+0.4%) | $6.68 M(+53.2%) |
| June 2020 | - | $2.31 M(+12.7%) | $4.36 M(+112.7%) |
| Mar 2020 | - | $2.05 M | $2.05 M |
| Dec 2019 | $5.77 M | - | - |
FAQ
- What is Century Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Century Therapeutics?
- What is Century Therapeutics annual SG&A year-on-year change?
- What is Century Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Century Therapeutics?
- What is Century Therapeutics quarterly SG&A year-on-year change?
- What is Century Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Century Therapeutics?
- What is Century Therapeutics TTM SG&A year-on-year change?
What is Century Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of IPSC is $34.71 M
What is the all time high annual SG&A for Century Therapeutics?
Century Therapeutics all-time high annual selling, general & administrative expenses is $34.71 M
What is Century Therapeutics annual SG&A year-on-year change?
Over the past year, IPSC annual selling, general & administrative expenses has changed by +$2.85 M (+8.94%)
What is Century Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of IPSC is $8.35 M
What is the all time high quarterly SG&A for Century Therapeutics?
Century Therapeutics all-time high quarterly selling, general & administrative expenses is $8.99 M
What is Century Therapeutics quarterly SG&A year-on-year change?
Over the past year, IPSC quarterly selling, general & administrative expenses has changed by -$634.00 K (-7.06%)
What is Century Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of IPSC is -$2.80 B
What is the all time high TTM SG&A for Century Therapeutics?
Century Therapeutics all-time high TTM selling, general & administrative expenses is $34.71 M
What is Century Therapeutics TTM SG&A year-on-year change?
Over the past year, IPSC TTM selling, general & administrative expenses has changed by -$2.84 B (-8251.90%)